Last quarter (Q3 2025), Werewolf Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Werewolf Therapeutics's net income was $-16.37M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 1.89M	$ 19.94M	$ 16.40M	$ 0.00	$ 0.00
Gross Profit	$ 71.00K	$ 18.18M	$ 13.89M	$ 0.00	$ -777.00K
Operating Expenses	$ 73.67M	$ 58.68M	$ 69.95M	$ 50.09M	$ 21.63M
Depreciation and Amortization	$ 1.81M	$ 1.76M	$ 2.51M	$ 216.00K	$ 777.00K
EBITDA	$ -64.05M	$ -32.47M	$ -51.30M	$ -49.87M	$ -14.26M
Operating Income	$ -73.59M	$ -40.50M	$ -56.06M	$ -50.09M	$ -22.40M
Other Income/Expenses	$ 3.08M	$ 3.13M	$ 2.25M	$ 104.00K	$ 7.36M
Pretax Income	$ -70.52M	$ -37.37M	$ -53.81M	$ -49.98M	$ -15.04M
Net Income	$ -70.52M	$ -37.37M	$ -53.81M	$ -49.98M	$ -14.94M
Per Share Metrics
Basic EPS	$ -1.63	$ -1.05	$ -1.86	$ -10.94	$ -0.98
Diluted EPS	$ -1.63	$ -1.05	$ -1.86	$ -10.94	$ -0.98
Weighted Average Shares Outstanding	43.33M	35.65M	28.86M	18.45M	28.66M
Weighted Average Shares Outstanding (Diluted)	43.86M	35.65M	28.86M	18.45M	28.66M

Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing